Flagship Ventures Fund IV, L.P.

10% Owner
Flagship Ventures Fund IV, L.P.
$381,843,000.00
%
COMPANY
SHARES
NET TOTAL
97.96%
Seres Therapeutics Inc
14,083,579
$374,060,000.00
1.92%
T2 Biosystems, Inc.
741,755
$7,314,000.00
0.12%
Eleven Biotherapeutics, Inc.
1,466,417
$469,000.00